为您找到相关结果约500个

你是不是要搜索 期刊DAA清除HCV可改变肝硬化患者的可溶性炎症介质 点击跳转

DAA-mediated HCV cure reduces HIV DNA levels in HCV/HIV coinfected people

Resistance Associated Mutations in HCV Patients Failing DAA Treatment

Persistence of Cryoglobulinemic Vasculitis after DAA Induced HCV Cure

Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA)

HCC recurrence after DAA treatment in HCV patients

HCC recurrence after DAA treatment in HCV patients

HCC RECURRENCE AFTER DAA TREATMENT IN HCV PATIENTS

Prevalence and origin of rare HCV Genotypes in DAA-naive and DAA-experienced patients

Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in AcuteHCV Infection

DAA Treatment Failure in a HIV/HBV/HCV Co-Infected Patient Carrying a Chimeric HCV Genotype 4/1b

DIRECT ACTING ANTIVIRAL (DAA) THERAPY IN REAL WORLD HCV COMPENSATED CIRRHOSIS

Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected

Treatment and re-treatment results of HCV patients in the DAA era

Risk of HBV Reactivation in Patients Infected with HBV/HCV Treated with DAA

Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure

为您找到相关结果约500个

共500条页码: 1/34页15条/页